Change Country
Welcome to LuxembourgWelcome
Please read the important information below before continuing to our website

The Lyxor ETFs on this website may be restricted for certain individuals or in certain countries pursuant to the national regulations applicable to those individuals or countries. It is therefore your responsibility to ensure that you are authorised to invest in the Lyxor ETFs on this website. 


If you are an investor in the United Kingdom, please go to  

If you are an investor in the Netherlands, please go to  

If you are an investor in Italy, please go to  

If you are an investor in Spain, please go to  

If you are an investor in Austria, please go to  

If you are an investor in Germany, please go to   

If you are an investor in Singapore, please go to  

If you are an investor in Switzerland, please go to  

If you are an investor in Belgium, please go to  

If you are an investor in Poland, please go to 

If you are an investor in Norway, please go to

If you are an investor in Denmark, please go to

If you are an investor in Luxembourg, please go to

If you are an investor in Sweden, please go to

If you are an investor in Finland, please go to



The Lyxor ETFs on this website are undertakings for collective investment in transferable securities (UCITS) (i) domiciled in France and approved by the Autorité des Marchés Financiers (AMF) or, (ii) domiciled in Luxembourg, approved by the Commission de Surveillance du Secteur Financier (CSSF) and authorised to market their units or shares in the French Republic in accordance with the notification procedure under Article 93 of Directive 2009/65/EC. Investors should note that the prospectuses of certain Lyxor ETFs under Luxembourg law that have been notified in accordance with this procedure are only available on the website in English. A French translation of these prospectuses can be obtained upon request by sending a letter to Lyxor International Asset Management (“Lyxor”) – 17 Cours Valmy, 92987 Paris La Défense, France.


The information on this website is not intended for persons or entities that are resident, located or registered in jurisdictions that are not authorised to distribute Lyxor ETFs. As a result, the information on this website does not constitute an offer or solicitation to buy or sell units or shares in these ETFs by anyone in any jurisdiction:


(a)   in which such an offer or solicitation is unauthorised;

(b)   in which Lyxor is not qualified to make such an offer or solicitation; or 

(c)   in which it is unlawful to make such an offer or solicitation.


In particular, the Lyxor ETFs on this website are not and will not be registered under the United States Securities Act of 1933, as amended. As such, they may not be offered or sold within the United States of America, except in specific cases where transactions are exempt from registration under the Securities Act. The ETFs listed on this website may not be sold to US citizens or transferred to the United States by any other means, unless this transaction is not subject to any specific registration under US law. 


Any person from a jurisdiction to which the above-mentioned restrictions apply should inform themselves of and observe these restrictions.


This website is intended for commercial purposes and is not regulatory in nature. Although the information provided has been drawn up on the basis of sources considered to be reliable, there is no guarantee that it is accurate, complete or relevant. Some of the information on this website is provided on the basis of market data collected at a specific time and may therefore vary over time. Lyxor advises investors to read the risk factors section of the prospectus and the key investor information document carefully. These documents can be found on the website.


The net asset value (“NAV”) of Lyxor ETFs may at any time be subject to considerable price fluctuations, which in some cases may lead to the loss of all of the capital invested. Investors should note that some ETFs may be sensitive to fluctuations in the exchange rate between their reference currency and that of the underlying index, as well as of the components of the underlying index.


Before investing in a Lyxor ETF, you should carry out your own risk analysis of the product from a legal, tax and accounting perspective, rather than basing your decision solely on the information provided. If necessary, you should consult your own advisers or any other qualified professional. 


Subject to compliance with the legal obligations by which they are bound, Lyxor or any entity within the same group shall not be held liable for any financial or other consequences of an investment in the product. 



By clicking on institutional or individual above, I confirm that I have read and understood the information provided herein, and that I am resident or registered in Luxembourg.


20 Apr 2018

What rising inflation means for your US investments

After a number of years in which central banks were more concerned with fighting the risks of deflation, several signs point to a higher inflation environment in the US. Over the last 12 months, oil prices have shot up by almost 30%. The US economy is now at "full" employment, with businesses reporting a shortage of skilled workers and an unemployment rate below 5%. Wage growth - initially sluggish - has also started to pick up in recent months, albeit without inducing major wage gains as yet.  According to OECD estimates, growth should remain above potential this year with the usage of industrial production capacity currently running at close to 80%. We believe such pressures in the productive apparatus will eventually translate into higher consumer prices.

Some of these effects are already apparent. For the first time in almost a year, headline inflation (CPI) and core inflation (which excludes volatile components such as energy prices) printed above the Fed’s 2.0% target in March. Higher inflation could well propel the push for higher speed policy normalisation. According to the March FOMC Minutes, Fed officials have grown more confident in the inflation outlook, barring the realisation of downside risks to their projections. Strong inflation reports in March and April should keep the Fed on track for a 25 basis points rate hike in June - and enable it to deliver four in total this year. However, we do not believe that the inflation rate will ramp up too dramatically in the period ahead. Technological developments in areas such as healthcare or communications, unconventional petroleum production and greater investment in productive capacities are factors that could counter at least some of the inflationary pressures.


US headline and core inflation both ahead of the Fed’s 2% target in March

                     chart 1 Us headline

Source: Lyxor International AM, Reuters Eikon Analytics.  Data as at 31 March 2018

Asset selection becomes more complicated

Despite the relatively benign nature of the above, investors are concerned by other issues. Asset allocation has become more complex given greater political risk (like the possible trade war between the US and China, less support from central banks and the high valuations most traditional asset classes are displaying. As a result, we expect to see a volatility regime shift, with markets much more volatile than they have been in recent years. Some of the market moves we’ve seen in February and March were, in our view, the precursors for this period of instability.

The positive correlation between the returns of fixed income and equity assets also impedes efforts to diversify portfolios more effectively. Historically, an investor who adopts a more cautious position tends to reduce their exposure to equities and increase their weighting to fixed income. That may not however be wise in a rising inflation environment where greater caution is required on conventional bonds. Inflation-linked bonds may be better suited to this new normal.

Right place, right time

Our research shows assets related to inflation tend to perform well in the more advanced stages of the economic cycle. The expansion in the US is undoubtedly entering old age - so the probability of a recession in the next two years is increasing. 

Holding commodities, most notably petroleum products, tends to prove beneficial in advanced stages of the cycle (especially 12 months before a recession), both in terms of absolute and risk-adjusted returns. The analysis takes into account economic cycles in the US, as measured by the NBER, since 1970. Inflation breakevens have been fairly supported by the recent move in energy/ oil prices (Brent above $72/bbl on 17 April). Net flows into short -dated TIPS ETFs have been fairly robust over the past month (despite net outflows in March in all-maturities ETFs). While energy price moves are difficult to predict in the near-term, the possibility of weather-related or geopolitically induced spike in oil prices remains. They should nonetheless continue to underpin perceptions of higher inflation. Inflation prints, on the other hand will continue to benefit from positive base effects (temporary slowdown in telecommunications and airfares in 2017) ahead of the summer. 

Key calls

For now then, we are looking to overweight assets such as TIPs and inflation breakevens, as well as commodities and those equity sectors that are most sensitive to inflation expectations.

In equities, as we said last week, Energy stocks offer a good proxy to oil prices and US inflation breakevens. The global energy sector offers an attractive dividend yield of around 3.75% (i.e. positive carry) vs. the negative carry of investing in futures-based strategies. The latter underperform when the futures curve is in contango (futures price above the expected spot price) - which is typically the case with Oil. Financials also remain a pure cheap way to play global reflation.

Whether you choose TIPs or breakevens depends on your view on where inflation goes next. TIPs are the conventional choice, but breakevens may be a better play if you believe people are underestimating just how high inflation could climb.

Energy stocks: a good proxy to US inflation breakevens

                        Chart 2 Energy stocks

Source: Lyxor International AM, MSCI, Bloomberg. Data as at 31 March 2018 

Why Lyxor for inflation

Lyxor has the most far reaching and complete range of inflation-linked ETFs in Europe, with exposures covering the US, Europe and the UK. Our Core US TIPS ETF is the cheapest on the market at just 0.09%. If you’re looking to not only protect yourself against rising inflation but also rising rates, our unique inflation expectations ETFs are designed to tackle both. With over 12 years’ experience managing inflation-related ETFs, and €3.3bn in AuM, look no further for dependable solutions to rising inflation.

Other ways to ride the inflation wave include investing in commodities, or targeting certain sectors. Our broad commodities ETF launched in 2006 tracks the Thomson Reuters/CRB index, a reference benchmark with over 50 years’ track record. It was the most widely traded broad commodities ETF in Europe over the past 5 years. We also offer 10 ways to access global equity sectors, with some of the oldest and largest ETFs of their kind in Europe. Our MSCI World Energy, Materials and Financials ETFs were the most efficient in the market over the past year.*


*Source: Lyxor International Asset Management. Data as at 31/01/2018. Statements refer to European ETF market. Efficiency data is based on the efficiency indicator created by Lyxor ‘s research department in 2013. It examines 3 components of performance: tracking error, liquidity and spread purchase/sale. Each peer group includes the relevant Lyxor ETF share-class and the 4 largest ETF share-classes issued by other providers, representing market-share of at least 5% on the relative index. ETF sizes are considered as an average of AUM levels observed over the relevant time period. Detailed methodology may be found in the paper ‘Measuring Performance of Exchange Traded Funds’ by Marlène Hassine and Thierry Roncalli. Statements refer to European ETF market. Past performance is no guide to future returns.

Risk Warning


Fund and charge data: Lyxor ETF, correct as at  20 April  2018.

This document is for the exclusive use of investors acting on their own account and categorized either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2004/39/EC. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on, and upon request to

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Lyxor International Asset Management (LIAM), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive (2009/65/EU) and the AIFM Directive (2011/31/EU). LIAM is represented in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website

Conflicts of interest 

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin